Literature DB >> 29123608

The effects of microRNA-34a regulating Notch-1/NF-κB signaling pathway on lipopolysaccharide-induced human umbilical vein endothelial cells.

Yun Ge1, Man Huang1, Yue-Feng Ma1.   

Abstract

BACKGROUND: Notch-1/NF-κB signaling plays a key role in the cecal ligation and puncture (CLP)-induced sepsis. This study aims to investigate the intervention effects of microRNA-34a (miR-34a) lentivirus regulating Notch-1/NF-κB signaling pathway on lipopolysaccharide (LPS)-induced human umbilical vein endothelial cells (HUVEC).
METHODS: HUVEC were divided into four groups as the following: they were infected with negative control lentivirus (NC group) or miR-34a lentivirus (OE group); LPS (1 μg/mL) was added on the third day on the basis of NC group and OE group for 24 hours (NC+LPS group or OE+LPS group). The levels of TNF-α, IL-1β, IL-6, and IL-10 in the cell supernatants, and the mRNA and protein expression of Notch-1 and NF-κB in the HUVEC were evaluated.
RESULTS: After 24 hours, the levels of TNF-α, IL-1β, IL-6 in the cell supernatants and the protein expression of NF-κB from NC+LPS group were significantly higher than those of NC group, but IL-10 level and the protein expression of Notch-1 in NC+LPS group were the opposite. After intervention of miR-34a lentivirus, the cell supernatants TNF-α and the protein expression of NF-κB in OE+LPS group after 24 hours markedly decreased compared to NC+LPS group. While the cell supernatants IL-1β and IL-6 and the mRNA expression of NF-κB slightly decreased in OE+LPS group, IL-10 and the mRNA and protein expression of Notch-1 were the opposite.
CONCLUSION: miR-34a regulating Notch-1/NF-κB signaling pathway can reduce the HUVEC damage caused by LPS stimulation.

Entities:  

Keywords:  Human umbilical vein endothelial cells; Lentivirus; MicroRNA-34a; NF-κB; Notch-1

Year:  2017        PMID: 29123608      PMCID: PMC5675971          DOI: 10.5847/wjem.j.1920-8642.2017.04.008

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  20 in total

Review 1.  Endothelium as a therapeutic target in sepsis.

Authors:  William C Aird
Journal:  Curr Drug Targets       Date:  2007-04       Impact factor: 3.465

Review 2.  The sirens' songs of confirmatory sepsis trials: selection bias and sampling error.

Authors:  C Natanson; C J Esposito; S M Banks
Journal:  Crit Care Med       Date:  1998-12       Impact factor: 7.598

Review 3.  NF-κB in immunobiology.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

4.  Circulating endothelial cells in patients with septic shock.

Authors:  M Mutunga; B Fulton; R Bullock; A Batchelor; A Gascoigne; J I Gillespie; S V Baudouin
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

Review 5.  Regulation of NF-κB induction by TCR/CD28.

Authors:  Jing Cheng; Angela Montecalvo; Lawrence P Kane
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

6.  MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia.

Authors:  Marek Mraz; Dasa Dolezalova; Karla Plevova; Katerina Stano Kozubik; Veronika Mayerova; Katerina Cerna; Katerina Musilova; Boris Tichy; Sarka Pavlova; Marek Borsky; Jan Verner; Michael Doubek; Yvona Brychtova; Martin Trbusek; Ales Hampl; Jiri Mayer; Sarka Pospisilova
Journal:  Blood       Date:  2012-01-10       Impact factor: 22.113

7.  Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes.

Authors:  F X Zhang; C J Kirschning; R Mancinelli; X P Xu; Y Jin; E Faure; A Mantovani; M Rothe; M Muzio; M Arditi
Journal:  J Biol Chem       Date:  1999-03-19       Impact factor: 5.157

8.  MicroRNA-23b promotes tolerogenic properties of dendritic cells in vitro through inhibiting Notch1/NF-κB signalling pathways.

Authors:  J Zheng; H-Y Jiang; J Li; H-C Tang; X-M Zhang; X-R Wang; J-T Du; H-B Li; G Xu
Journal:  Allergy       Date:  2012-01-09       Impact factor: 13.146

9.  Notch1 augments NF-kappaB activity by facilitating its nuclear retention.

Authors:  Hyun Mu Shin; Lisa M Minter; Ok Hyun Cho; Sridevi Gottipati; Abdul H Fauq; Todd E Golde; Gail E Sonenshein; Barbara A Osborne
Journal:  EMBO J       Date:  2005-12-01       Impact factor: 11.598

10.  Γ-secretase inhibitor DAPT prevents neuronal death and memory impairment in sepsis associated encephalopathy in septic rats.

Authors:  Man Huang; Chunhui Liu; Yueyu Hu; Pengfei Wang; Meiping Ding
Journal:  Chin Med J (Engl)       Date:  2014       Impact factor: 2.628

View more
  5 in total

1.  Dose-related effects of dexmedetomidine on immunomodulation and mortality to septic shock in rats.

Authors:  Yan Ma; Xiang-You Yu; Yi Wang
Journal:  World J Emerg Med       Date:  2018

2.  Late-onset neonatal sepsis: genetic differences by sex and involvement of the NOTCH pathway.

Authors:  Timothy H Ciesielski; Xueyi Zhang; Scott M Williams; Giorgio Sirugo; Alessandra Tacconelli; Irja Lutsar; Vincent Meiffredy de Cabre; Emmanuel Roilides; Cinzia Ciccacci; Paola Borgiani; William K Scott
Journal:  Pediatr Res       Date:  2022-07-14       Impact factor: 3.953

3.  Inhibition of miRNA-34a Promotes M2 Macrophage Polarization and Improves LPS-Induced Lung Injury by Targeting Klf4.

Authors:  Mohd Junaid Khan; Prithvi Singh; Ravins Dohare; Rishabh Jha; Arshad H Rahmani; Saleh A Almatroodi; Shakir Ali; Mansoor Ali Syed
Journal:  Genes (Basel)       Date:  2020-08-20       Impact factor: 4.096

Review 4.  Role of miRNA dysregulation in sepsis.

Authors:  Amanda Formosa; Paul Turgeon; Claudia C Dos Santos
Journal:  Mol Med       Date:  2022-08-19       Impact factor: 6.376

5.  Notch signaling protects CD4 T cells from STING-mediated apoptosis during acute systemic inflammation.

Authors:  Junke Long; Chenxuan Yang; Yawen Zheng; Patricia Loughran; Fu Guang; Yiming Li; Hong Liao; Melanie J Scott; Daolin Tang; Timothy R Billiar; Meihong Deng
Journal:  Sci Adv       Date:  2020-09-23       Impact factor: 14.136

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.